Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-01-30 · accession 0001593968-24-000449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-06 | 2024-01-30 | ALLO | Parker Geoffrey M. | CFO | P - Purchase | $3.60 | +190 | 819.6K | +0.0% | +$684 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-30 | P | A | 190 | $3.60 | 819,590 | D | — | — | (F1) Mr. Parker was notified by his broker on March 4, 2024 that these shares were purchased in an account held by the Geoffrey M. Parker and Jill G. Parker Rev. Trust dated January 27, 2000 for which Mr. Parker does not have discretion. This account is intended to closely track the performance of the Russell 2000 and is frequently rebalanced by an algorithm designed by the broker which led to the purchase of these shares. Restrictions have been now placed on all such accounts held by the Trust to avoid such purchases of the Issuer stock in the future. |